title: [Infliximab treatment of severe bleeding complicating Crohn's disease].
authors.forename: L
authors.initials: L
authors.lastname: Julián Gómez
authors.forename: R
authors.initials: R
authors.lastname: Atienza
authors.forename: J
authors.initials: J
authors.lastname: Barrio
authors.forename: P
authors.initials: P
authors.lastname: Gil
authors.forename: S
authors.initials: S
authors.lastname: Gómez de la Cuesta
authors.forename: P
authors.initials: P
authors.lastname: Pinto
authors.forename: N
authors.initials: N
authors.lastname: Alcaide
authors.forename: A
authors.initials: A
authors.lastname: Caro Patón
mesh_terms: D015746:Abdominal Pain / Q000209:etiology; D000038:Abscess / Q000209:etiology; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003082:Colectomy; D003093:Colitis, Ulcerative / Q000601:surgery; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D006471:Gastrointestinal Hemorrhage / Q000209:etiology*; D006801:Humans; D007081:Ileostomy; D000069285:Infliximab; D008297:Male; D008532:Megacolon, Toxic / Q000209:etiology / Q000601:surgery; D011183:Postoperative Complications / Q000209:etiology / Q000601:surgery; D012086:Reoperation; D014456:Ulcer / Q000209:etiology
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab